Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
McKinsey
Johnson and Johnson
QuintilesIMS
Farmers Insurance
Argus Health
US Department of Justice
Dow
Accenture

Generated: August 21, 2017

DrugPatentWatch Database Preview

PROMETRIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Prometrium, and what generic Prometrium alternatives are available?

Prometrium is a drug marketed by Virtus Pharms and is included in one NDA.

The generic ingredient in PROMETRIUM is progesterone. There are fifty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the progesterone profile page.

Summary for Tradename: PROMETRIUM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list7
Bulk Api Vendors: see list70
Clinical Trials: see list14
Patent Applications: see list9,775
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROMETRIUM at DailyMed

Pharmacology for Tradename: PROMETRIUM

Ingredient-typeProgesterone
Drug ClassProgesterone
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Virtus Pharms
PROMETRIUM
progesterone
CAPSULE;ORAL019781-001May 14, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
Virtus Pharms
PROMETRIUM
progesterone
CAPSULE;ORAL019781-002Oct 15, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
Virtus Pharms
PROMETRIUM
progesterone
CAPSULE;ORAL019781-003Oct 15, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Fuji
Teva
Federal Trade Commission
Chubb
Dow
Novartis
Daiichi Sankyo
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot